Skip to main content
Top
Published in: Endocrine 1/2022

01-01-2022 | Spironolactone | Correction

Correction: Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism

Authors: Christian Adolf, Leah T. Braun, Carmina T. Fuss, Stefanie Hahner, Heike Künzel, Laura Handgriff, Lisa Sturm, Daniel A. Heinrich, Holger Schneider, Martin Bidlingmaier, Martin Reincke

Published in: Endocrine | Issue 1/2022

Login to get access

Excerpt

Correction to: Endocrine (2020) 69:625–633 …
Metadata
Title
Correction: Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism
Authors
Christian Adolf
Leah T. Braun
Carmina T. Fuss
Stefanie Hahner
Heike Künzel
Laura Handgriff
Lisa Sturm
Daniel A. Heinrich
Holger Schneider
Martin Bidlingmaier
Martin Reincke
Publication date
01-01-2022
Publisher
Springer US
Keyword
Spironolactone
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02905-9

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.